Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Paul Awolade

Concepts (100)

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Paul Awolade's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Paul Awolade has written about over time.
Glucuronidase, 1 publications between 2019 and 2019, average publication date December 2019. Glycoproteins, 1 publications between 2019 and 2019, average publication date December 2019. Anti-Bacterial Agents, 4 publications between 2019 and 2021, average publication date April 2020. Aminoquinolines, 2 publications between 2019 and 2020, average publication date April 2020. Molecular Structure, 10 publications between 2018 and 2021, average publication date May 2020. Microbial Sensitivity Tests, 5 publications between 2019 and 2021, average publication date May 2020. Triazoles, 3 publications between 2020 and 2021, average publication date June 2020. Dose-Response Relationship, Drug, 6 publications between 2019 and 2021, average publication date August 2020. Structure-Activity Relationship, 11 publications between 2018 and 2024, average publication date October 2020. Isatin, 1 publications between 2021 and 2021, average publication date January 2021. Methicillin-Resistant Staphylococcus aureus, 1 publications between 2021 and 2021, average publication date January 2021. Thiadiazoles, 2 publications between 2020 and 2021, average publication date February 2021. Antineoplastic Agents, 8 publications between 2018 and 2024, average publication date May 2021. Hypoglycemic Agents, 4 publications between 2018 and 2024, average publication date May 2021. Quinolines, 3 publications between 2020 and 2024, average publication date November 2021. Cell Survival, 3 publications between 2020 and 2024, average publication date February 2022. Antitubercular Agents, 2 publications between 2020 and 2024, average publication date June 2022. Glycoside Hydrolase Inhibitors, 2 publications between 2021 and 2024, average publication date November 2022. DNA Helicases, 4 publications between 2022 and 2024, average publication date November 2023. DNA-Binding Proteins, 4 publications between 2022 and 2024, average publication date November 2023.

To see the data from this visualization as text, click here.
Awolade's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)